Asia Pacific Platelet Rich Plasma (prp) Market Size & Outlook
Asia Pacific platelet rich plasma (prp) market, 2018-2030 (US$M)
Related Markets
Asia Pacific platelet rich plasma (prp) market highlights
- The Asia Pacific platelet rich plasma (prp) market generated a revenue of USD 131.4 million in 2023.
- The market is expected to grow at a CAGR of 17.2% from 2024 to 2030.
- In terms of segment, pure prp was the largest revenue generating type in 2023.
- Leukocyte Rich PRP is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Japan is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 131.4 million |
| Market revenue in 2030 | USD 399.9 million |
| Growth rate | 17.2% (CAGR from 2023 to 2030) |
| Largest segment | Pure prp |
| Fastest growing segment | Leukocyte Rich PRP |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pure PRP, Leukocyte Rich PRP |
| Key market players worldwide | Johnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 20.3% of the global platelet rich plasma (prp) market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 399.9 million by 2030.
Pure prp was the largest segment with a revenue share of 49.7% in 2023. Horizon Databook has segmented the Asia Pacific platelet rich plasma (prp) market based on pure prp, leukocyte rich prp covering the revenue growth of each sub-segment from 2018 to 2030.
The Asia Pacific market is expected to witness the fastest growth in the near future. The rising number of cosmetic surgeries to improve facial features in Korea, India, and Thailand is anticipated to boost the regional market. In addition, growing medical tourism industry is expected to boost the adoption of PRP treatments.
In some cases, PRP therapy can prevent the need for surgery, which is aiding in market growth. This includes treating damaged tissues to prevent damage progression in orthopedics, joint replacement, and spinal fusion. The presence of a strong research base for PRP therapies is expected to boost their adoption in the region.
China, Japan, and India are significantly contributing to the region's market growth. Active involvement of academic and research institutes, such as the University of Tsukuba and Guangzhou University of Chinese Medicine, for evaluating the application of PRP therapies is expected to fuel the market.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Platelet Rich Plasma (PRP) Market Scope
Platelet Rich Plasma (PRP) Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific platelet rich plasma (prp) market size, by country, 2018-2030 (US$M)
Asia Pacific Platelet Rich Plasma (PRP) Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
